Company Filing History:
Years Active: 2001-2017
Title: Innovations by Anthony John Milici
Introduction
Anthony John Milici is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of medical research, particularly in the assessment of muscular dystrophy and inflammatory responses in tissues. With a total of 7 patents, his work has the potential to impact patient care and treatment strategies.
Latest Patents
One of Milici's latest patents is focused on methods for quantitative assessment of muscle fibers in muscular dystrophy. This method involves assessing muscular dystrophy-linked protein expression in muscle fibers through digital image analysis of tissue samples. The process includes obtaining muscle tissue samples from patients, staining them for specific proteins, and analyzing the images using a computer algorithm. This innovative approach allows for the scoring of disease status, which can help infer disease severity and monitor therapeutic efficacy.
Another significant patent by Milici involves digital image analysis of inflammatory cells and mediators of inflammation. This method evaluates inflammatory responses in tumor tissue and other relevant tissue types. It includes obtaining and processing tissue samples, staining them to identify inflammatory cells, and using digital image analysis to quantify features within the tissue. The resulting summary score aids in patient stratification for therapeutic approaches.
Career Highlights
Throughout his career, Milici has worked with prominent companies such as Pfizer Corporation and Flagship Biosciences, Inc. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Milici has collaborated with notable individuals in his field, including Allen Jacob Duplantier and Louis Stanley Chupak. These collaborations have likely enriched his research and development efforts.
Conclusion
Anthony John Milici's contributions to medical research through his patents demonstrate his commitment to advancing healthcare solutions. His innovative methods for assessing muscular dystrophy and inflammatory responses highlight the importance of technology in improving patient outcomes.